BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30536036)

  • 1. Impact of chronic kidney dysfunction on serum Sulfatides and its metabolic pathway in mice.
    Yamada Y; Harada M; Hashimoto K; Guo R; Nakajima T; Kashihara T; Yamada M; Aoyama T; Kamijo Y
    Glycoconj J; 2019 Feb; 36(1):1-11. PubMed ID: 30536036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides.
    Zhang X; Nakajima T; Kamijo Y; Li G; Hu R; Kannagi R; Kyogashima M; Aoyama T; Hara A
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1382-8. PubMed ID: 19895791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of kidney injuries maintains serum sulfatide levels dependent on hepatic synthetic ability: a possible involvement of oxidative stress.
    Sheng X; Nakajima T; Wang L; Zhang X; Kamijo Y; Takahashi K; Tanaka N; Sugiyama E; Kyogashima M; Aoyama T; Hara A
    Tohoku J Exp Med; 2012 May; 227(1):1-12. PubMed ID: 22499158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hypertension and antihypertensive treatments on sulfatide levels in serum and its metabolism.
    Guo R; Hu X; Yamada Y; Harada M; Nakajima T; Kashihara T; Yamada M; Aoyama T; Kamijo Y
    Hypertens Res; 2019 May; 42(5):598-609. PubMed ID: 30531843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney dysfunction induced by protein overload nephropathy reduces serum sulfatide levels in mice.
    Li G; Hu R; Kamijo Y; Nakajima T; Aoyama T; Ehara T; Shigematsu H; Kannagi R; Kyogashima M; Hara A
    Nephrology (Carlton); 2009 Oct; 14(7):658-62. PubMed ID: 19796024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice.
    Kanbe H; Kamijo Y; Nakajima T; Tanaka N; Sugiyama E; Wang L; Fang ZZ; Hara A; Gonzalez FJ; Aoyama T
    Arch Toxicol; 2014 Feb; 88(2):367-79. PubMed ID: 24065054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of sulfatide as a major glycosphingolipid in WHHL rabbit serum lipoproteins.
    Hara A; Taketomi T
    J Biochem; 1987 Jul; 102(1):83-92. PubMed ID: 3667567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sulfatide abnormality is associated with increased oxidative stress in hemodialysis patients.
    Yuzhe H; Kamijo Y; Hashimoto K; Harada M; Kanno T; Sugiyama E; Kyogashima M; Oguchi T; Nakajima T; Kanno Y; Aoyama T
    Hemodial Int; 2015 Jul; 19(3):429-38. PubMed ID: 25645724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal sulfatides: sphingoid base-dependent localization and region-specific compensation of CerS2-dysfunction.
    Marsching C; Rabionet M; Mathow D; Jennemann R; Kremser C; Porubsky S; Bolenz C; Willecke K; Gröne HJ; Hopf C; Sandhoff R
    J Lipid Res; 2014 Nov; 55(11):2354-69. PubMed ID: 25267995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyunsaturated fatty acid deficiency affects sulfatides and other sulfated glycans in lysosomes through autophagy-mediated degradation.
    Wang Y; Nakajima T; Diao P; Yamada Y; Nakamura K; Nakayama J; Tanaka N; Aoyama T; Kamijo Y
    FASEB J; 2020 Jul; 34(7):9594-9614. PubMed ID: 32501606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of complex sulfatides SM3 and SB1a in mouse kidney using MALDI-TOF/TOF mass spectrometry.
    Marsching C; Eckhardt M; Gröne HJ; Sandhoff R; Hopf C
    Anal Bioanal Chem; 2011 Jul; 401(1):53-64. PubMed ID: 21359825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent PPARα activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene.
    Tian Y; Yang Y; Zhang X; Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Lu Y; Moriya K; Koike K; Gonzalez FJ; Aoyama T
    Glycoconj J; 2016 Dec; 33(6):927-936. PubMed ID: 27318478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.
    Kamijo Y; Wang L; Matsumoto A; Nakajima T; Hashimoto K; Higuchi M; Kyogashima M; Aoyama T; Hara A
    Clin Exp Nephrol; 2012 Dec; 16(6):959-67. PubMed ID: 22552383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and composition of sulfatides isolated from livers of patients with metachromatic leukodystrophy: galactosyl sulfatide and lactosyl sulfatide.
    Sugita M; Dulaney JT; Moser HW
    J Lipid Res; 1974 May; 15(3):227-33. PubMed ID: 4363968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of galactose and sulfate residues in sulfatides for their antagonistic functions in the blood coagulation system.
    Kyogashima M; Sakai T; Onaya J; Hara A
    Glycoconj J; 2001 Mar; 18(3):245-51. PubMed ID: 11602808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Sulfatide, A Novel Biomarker for ST-Segment Elevation Myocardial Infarction.
    Li G; Hu R; Guo Y; He L; Zuo Q; Wang Y
    J Atheroscler Thromb; 2019 Jan; 26(1):84-92. PubMed ID: 29887538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfatides are required for renal adaptation to chronic metabolic acidosis.
    Stettner P; Bourgeois S; Marsching C; Traykova-Brauch M; Porubsky S; Nordström V; Hopf C; Koesters R; Sandhoff R; Wiegandt H; Wagner CA; Gröne HJ; Jennemann R
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9998-10003. PubMed ID: 23716689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease.
    Hamano H; Ikeda Y; Watanabe H; Horinouchi Y; Izawa-Ishizawa Y; Imanishi M; Zamami Y; Takechi K; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    Nephrol Dial Transplant; 2018 Apr; 33(4):586-597. PubMed ID: 28992067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.